20
https://pubmed.ncbi.nlm.nih.gov/38112196
The SH-SY5Y cell line, a human-derived neuronal model with catecholaminergic attributes, holds significant potential as a high-throughput screening tool for Parkinson’s disease drug discovery, including assessing therapeutic efficacy, toxicity, and nanocarrier delivery across the blood-brain barrier.